Dr. David Piper

Dr. David Piper, Director of R&D at Thermo Fisher Scientific, discusses groundbreaking innovations in disease modeling, particularly for Parkinson's. He highlights the potential of iPS technology in drug screening and the challenges of consistent stem cell production. The conversation delves into the impact of alcohol and BPA on health, while emphasizing collaborations with the Parkinson's Institute to develop effective research tools. Piper also shares insights on genome editing techniques like CRISPR and innovative methodologies for studying complex diseases.